Profil
Oliver Buck is the founder of OncoBeta GmbH.
He is currently a Trustee at the International Centers for Precision Oncology Foundation and a Member-Supervisory Board at ITM Isotope Technologies Munich SE.
Previously, he served as a Non-Independent Non-Executive Director at Telix Pharmaceuticals Ltd. from 2017 to 2022.
Mr. Buck graduated from Technische Universität München.
Postes actifs de Oliver Buck
| Sociétés | Poste | Début |
|---|---|---|
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Directeur/Membre du Conseil | 01/01/2012 |
International Centers for Precision Oncology Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Oliver Buck
| Sociétés | Poste | Fin |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 18/05/2022 |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Fondateur | - |
Formation de Oliver Buck
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Health Technology |
International Centers for Precision Oncology Foundation | |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Health Technology |
















